← Leaderboards
Stewart Andrew Low
Novosteo, Inc.
$2,024,882
Attributed
$2,024,882
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2018–20$2M$1.5M$1M$500K$0
'18
'19
'20
Funding mix
By agency
NIH$2,024,882 · 1
By mechanism
R44$2,024,882 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Acceleration”
- Joel A Lipkin · Four Points Technology, Llc$183,862,844
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$96,326,191
- Terry Drinkwine · Carahsoft Technology Corporation$93,741,163
- Mark Marino · Venturewell$61,502,138
- Klaus Romero · Critical Path Institute$58,665,332
Research focus
AccelerationAging PopulationAnabolic AgentsAnimal ModelAnimalsAutocrineBiodistributionBolus InfusionBoneBone CallusBone GrowthBone QualityBone RegenerationBypassCanis FamiliarisCessation Of LifeChargeChemistryClinicClinical TrialsConventional TherapyCostCraniofacialDesign